EP Patent

EP2740492A1 — Triazine formulations with a second active ingredient and surfactant(s)

Assigned to Ceva Sante Animale SA · Expires 2014-06-11 · 12y expired

What this patent protects

The present invention is relative to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to …

USPTO Abstract

The present invention is relative to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.

Drugs covered by this patent

Patent Metadata

Patent number
EP2740492A1
Jurisdiction
EP
Classification
—
Expires
2014-06-11
Drug substance claim
No
Drug product claim
No
Assignee
Ceva Sante Animale SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.